Major LBTs from EuroPCR 2025 - Meta-Analysis of individual patient data from the PROTECTED TAVR and BHF PROTECT-TAVI studies
Update: 2025-09-18
Description
How effective is cerebral protection during TAVI?
Bernard Prendergast and Rajesh Kharbanda take a deep dive into this key procedural question, reviewing the latest evidence from two major randomised trials—PROTECTED TAVR and BHF PROTECT-TAVI.
Although both studies individually failed to demonstrate a clinical benefit for cerebral protection devices, a new patient-level meta-analysis presented at #EuroPCR2025 offers fresh insights.
Listen to this episode now to understand how aligning endpoints and patient profiles has helped uncover new signals that could shape future practice.
Hosted on Acast. See acast.com/privacy for more information.
CommentsÂ
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
